185 results
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
5 Jan 24
Results of Operations and Financial Condition
5:01pm
% Industrial / Pharma 20% Americas 47% EMEA 28% APAC 25% 2022 REVENUE BY CUSTOMER TYPE 2022 REVENUE BY GEOGRAPHY Revenues allocations are approximate ▪ … Essential, secular growth markets, high barriers, few competitors Growing global marquee customer base High barrier innovative technologies Highly
8-K
EX-10.1
sad001nu5a6m4tkl7s
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-99.1
ked4cjr3n7r
25 Apr 23
Harvard Bioscience Announces First Quarter 2023 Financial Results
8:00am
SD
EX-1.01
j36u4yz0b25vxoaprg9
20 May 22
Conflict minerals disclosure
4:15pm
SD
EX-1.01
14j4gdi77h3nlckgyx
27 May 21
Conflict minerals disclosure
4:26pm